Subscribe to the latest updates in life science
Expert perspectives delivered to your inbox — pick your interests.
No spam, ever. Unsubscribe anytime.
Serialization in the EU can become a competitive advantage if you dare to innovate
In an attempt to reduce counterfeiting in the pharmaceutical industry, the European Union has issued the Falsified Medicine Directive (2011/62/EU).
January 16, 20190 min read
Keep reading
Related articles
Feb 13, 2026
Deciding Early on an Orphan Strategy: A Strategic Choice, Not a Checkbox
Orphan strategy decisions go beyond incentives. Learn how regulatory definitions, evidence requirements, timing, and exclusivity across the EU, US, and UK shape early biotech development strategy.
Read more
Feb 9, 2026
Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights
Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
Read more
Oct 27, 2025
Environmental Risk Assessments (ERA) in Pharma: Balancing Health & Environment
Explore how Environmental Risk Assessment (ERA) helps ensure medicines heal us without harming the planet, balancing healthcare advances with ecological preservation.
Read more